MARTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 18.250
AS - Asia 9.305
EU - Europa 8.521
SA - Sud America 1.411
AF - Africa 239
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 5
Totale 37.776
Nazione #
US - Stati Uniti d'America 17.635
IT - Italia 4.036
SG - Singapore 3.361
CN - Cina 2.038
VN - Vietnam 1.111
BR - Brasile 1.107
DE - Germania 1.102
HK - Hong Kong 728
UA - Ucraina 563
GB - Regno Unito 553
FI - Finlandia 535
BD - Bangladesh 458
TR - Turchia 388
CA - Canada 378
NL - Olanda 360
FR - Francia 347
JP - Giappone 292
IN - India 258
RU - Federazione Russa 205
ID - Indonesia 166
SE - Svezia 158
MX - Messico 153
PL - Polonia 135
RO - Romania 117
AR - Argentina 106
ZA - Sudafrica 89
ES - Italia 86
IQ - Iraq 70
PK - Pakistan 67
LT - Lituania 50
AU - Australia 44
BE - Belgio 44
UZ - Uzbekistan 41
AT - Austria 40
CO - Colombia 39
EC - Ecuador 39
MY - Malesia 37
SA - Arabia Saudita 36
CH - Svizzera 35
PH - Filippine 34
CZ - Repubblica Ceca 33
AE - Emirati Arabi Uniti 31
VE - Venezuela 30
MA - Marocco 29
CL - Cile 28
EG - Egitto 24
PE - Perù 23
KR - Corea 21
IR - Iran 20
KE - Kenya 18
TN - Tunisia 18
IL - Israele 17
PT - Portogallo 17
TW - Taiwan 17
TH - Thailandia 16
PY - Paraguay 15
JM - Giamaica 14
DZ - Algeria 13
BO - Bolivia 12
HN - Honduras 12
IE - Irlanda 12
JO - Giordania 12
NP - Nepal 12
AZ - Azerbaigian 11
HU - Ungheria 11
UY - Uruguay 11
KZ - Kazakistan 10
AL - Albania 9
DO - Repubblica Dominicana 9
GT - Guatemala 9
MD - Moldavia 9
PA - Panama 9
GR - Grecia 8
LB - Libano 8
SN - Senegal 8
DK - Danimarca 7
KG - Kirghizistan 7
OM - Oman 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
BY - Bielorussia 6
CR - Costa Rica 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
ET - Etiopia 5
LV - Lettonia 5
NG - Nigeria 5
RS - Serbia 5
CY - Cipro 4
LY - Libia 4
NO - Norvegia 4
RE - Reunion 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BS - Bahamas 3
CG - Congo 3
EE - Estonia 3
HR - Croazia 3
KW - Kuwait 3
SV - El Salvador 3
Totale 37.714
Città #
Ashburn 2.547
Singapore 2.149
San Jose 1.239
Fairfield 1.078
Woodbridge 980
Santa Clara 777
Dallas 762
Beijing 739
Hong Kong 695
Houston 648
Chandler 605
Munich 570
Jacksonville 545
Los Angeles 450
Seattle 444
New York 443
Ann Arbor 393
Wilmington 391
Cambridge 379
Milan 377
Council Bluffs 352
Ho Chi Minh City 344
Ferrara 340
Helsinki 289
Hanoi 276
Tokyo 266
Rome 228
Orem 207
Izmir 196
Lauterbourg 164
Princeton 159
Shanghai 143
Nanjing 142
San Francisco 135
Boardman 134
Bologna 130
London 118
Denver 113
Jakarta 112
Toronto 110
San Diego 108
Warsaw 106
Chicago 104
Montreal 101
São Paulo 100
The Dalles 100
Brooklyn 99
Atlanta 94
Turku 94
Mexico City 85
Buffalo 84
Chennai 84
Hefei 71
Redwood City 68
Falkenstein 64
Boston 62
Da Nang 59
Florence 59
Phoenix 58
Amsterdam 56
Memphis 56
Johannesburg 55
Naples 53
Poplar 52
Stockholm 48
Frankfurt am Main 45
Haiphong 45
Bremen 43
Hebei 42
Moscow 41
Tianjin 41
Rio de Janeiro 40
Shenyang 40
Manchester 38
Turin 37
Falls Church 36
Tashkent 35
Washington 35
Brussels 34
Nuremberg 34
Verona 33
Ankara 32
Cagliari 31
Biên Hòa 30
Mumbai 28
Ottawa 28
Vancouver 28
Guangzhou 27
Mountain View 27
Nanchang 27
Norwalk 27
Querétaro 26
Changsha 25
Curitiba 25
Jiaxing 25
Genoa 24
Charlotte 22
Istanbul 22
San Mateo 22
Secaucus 22
Totale 23.206
Nome #
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 1.629
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 1.445
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 1.035
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence 755
New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat 431
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 417
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 413
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 394
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 378
Droghe da stupro: il GHB ed i suoi analoghi 360
The synthetic cathinones MDPHP and MDPV: Comparison of the acute effects in mice, in silico ADMET profiles and clinical reports 356
Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System 352
Choose the cause of death: a complex suicide 339
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 334
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 330
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 329
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 308
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 307
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 302
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 302
Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs 290
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 287
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 286
Un distillato Bohémienne tuttora famoso: l’assenzio 281
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 276
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 267
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 259
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 241
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 238
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 236
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 235
Antagonisti dei recettori NOP e loro usi terapeutici 233
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 231
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 229
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 228
Loss of cortical GABA terminals in Unverricht–Lundborg disease 228
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 224
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 221
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 218
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 217
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 217
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 216
JWH-018 impairs sensorimotor functions in mice 215
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 210
Application of 13 loci STR multiplex for the cannabis sativa genotyping 207
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 205
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 204
Application of 13 loci STR multiplex for cannabis sativa genotyping 204
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 202
Novel Synthetic Opioids: The Pathologist's Point of View 202
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 201
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 200
DNA recovery from immunochromatographic membranes 199
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 198
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 198
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 198
Ayahuasca: il vino dell'anima 194
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 192
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 191
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 191
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 191
Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish 191
Cutaneous miRNAs expression in human hanging injuries 190
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 190
In vitro and in vivo pharmaco-toxicological characterization of 1-cyclohexyl-x-methoxybenzene derivatives in mice: comparison with tramadol and PCP 190
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 189
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 187
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 187
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 186
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 184
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 184
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 182
In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45 180
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 178
DAG-MAG-BHB: A Novel Ketone Diester Modulates NLRP3 Inflammasome Activation in Microglial Cells in Response to Beta-Amyloid and Low Glucose AD-like Conditions 177
5-HT2A receptors are involved in the pharmaco-toxicological effects of the synthetic cannabinoids JWH-018 and 5F-PB22: In vivo studies in mice 175
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat 174
Comparison of N-methyl-2-pyrrolidone (NMP) and the “date rape” drug GHB: behavioral toxicology in the mouse model 174
Accidental Autoerotic Death: An Unusual Case of Lethal Asphyxiophilia Associated With Autogynephilia 173
MAM-2201 acute administration impairs motor, sensorimotor, prepulse inhibition, and memory functions in mice: a comparison with its analogue AM-2201 167
Reply to "MDPV-induced aggression in humans not established" 167
Mrna profiling in casework analyses 167
Behavioral and Pharmacokinetics Studies of N-Methyl-2-Aminoindane (NM2AI) in Mice: An Aminoindane Briefly Used in the Illicit Drug Market 166
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 166
Trichocereuspachanoi: quando la globalizzazione minaccia la tradizione. 166
Synthetic cannabinoid JWH-073 alters both acute behavior and in vivo/vitro electrophysiological responses in mice 165
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 165
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 164
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 164
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat 163
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 162
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 162
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 161
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 159
IL-15, CD-15 AND tryptase as markers of wound vitality in compressed neck skin: when conventional macroscopic and histological findings fail 158
Comprehensive evaluation of the pharmacological and toxicological effects of γ-valerolactone as compared to γ-hydroxybutyric acid: Insights from in vivo and in silico models 157
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 157
Metabolic profile of the synthetic drug 4,4′-dimethylaminorex in urine by LC–MS-based techniques: selection of the most suitable markers of its intake 157
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 157
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 156
Totale 26.373
Categoria #
all - tutte 149.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.545
Totale 150.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.602 179 145 81 150 232 177 104 133 226 28 93 54
2023/20241.386 96 105 65 48 123 204 76 107 56 82 77 347
2024/20256.429 206 174 532 318 550 749 487 475 945 551 805 637
2025/202617.448 1.620 652 1.554 1.763 2.309 1.106 1.882 1.034 1.530 1.829 1.351 818
2026/20271.848 1.848 0 0 0 0 0 0 0 0 0 0 0
Totale 38.160